Aurobindo Pharma has reported results for the second quarter ended September 30, 2013.
The company has reported 24.50% fall in its net profit at Rs 179.70 crore for the quarter as compared to Rs 238.01 crore for the same quarter in the previous year. However, total income of the company has increased by 14.49% at Rs 1600.05 crore for quarter under review as compared to Rs 1397.49 crore for the quarter ended September 30, 2012.
On the consolidated basis, the group has registered a growth of 5.67% in net profit after taxes and minority interest of Rs 234.95 crore as compared to Rs 222.35 crore in the same quarter previous year. Total income of the group rose 27.33% to Rs 1918.97 crore for quarter under review as against Rs 1507.03 crore in corresponding quarter previous year.
